Isoprazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H18N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LB0T3NEB48, chemically known as 1-propanone, 1-(4-amino-2-methyl-5-phenylpyrrol-3-yl)-2-methyl- but generally known as isoprazone, which bears US NIH Compound Identifier 71737. European Medicines Agency schedules Isoprazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08328MIG. The term ISOPRAZONE is an International Non-Proprietary Name. ISOPRAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isoprazone under HS 29339990 and SITC 51577. As of Q4 2014, ISOPRAZONE remains the US FDA Preferred Term for this commodity. Isoprazone bears US NLM identifiers UMLS ID C0621745 and NCI Concept Code C65981. SMILES: O=C(C1C([NH]C(C1N)C1CCCCC1)C)C(C)C.